Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Mohl

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2004
Continuous release of rh-interferon alpha-2a from triglyceride matricesSilke Mohl, Gerhard Winter
Pharmaceutical Development and Technology|March 21, 2006
Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage formsSilke Mohl, Gerhard Winter
The Journal of Pharmacy and Pharmacology|May 5, 2017
Challenges for the pharmaceutical technical development of protein coformulationsClaudia Mueller, Ulrike Altenburger, Silke Mohl
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 29, 2006
NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implantsTilo Schönbrodt, Silke Mohl, Gerhard Winter, et al.
PDA Journal of Pharmaceutical Science and Technology|June 2, 2018
Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and TransportationAlejandra Nieto, Holger Roehl, Michael Adler, et al.
Pharmaceutical Research|March 24, 2007
New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implantsSandra Herrmann, Silke Mohl, Florence Siepmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Mechanisms controlling protein release from lipidic implants: effects of PEG additionSandra Herrmann, Gerhard Winter, Silke Mohl, et al.
PDA Journal of Pharmaceutical Science and Technology|October 27, 2018
Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) ParenteralsJakob W Buecheler, Joerg Luemkemann, Henning Gieseler, et al.
PDA Journal of Pharmaceutical Science and Technology|January 23, 2016
Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product ManufacturingRoman Mathaes, Hanns-Christian Mahler, Yves Roggo, et al.
PDA Journal of Pharmaceutical Science and Technology|February 19, 2016
Impact of Vial Capping on Residual Seal Force and Container Closure IntegrityRoman Mathaes, Hanns-Christian Mahler, Yves Roggo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 19, 2004
Continuous release of rh-interferon alpha-2a from triglyceride matricesSilke Mohl, Gerhard Winter
Pharmaceutical Development and Technology|March 21, 2006
Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage formsSilke Mohl, Gerhard Winter
The Journal of Pharmacy and Pharmacology|May 5, 2017
Challenges for the pharmaceutical technical development of protein coformulationsClaudia Mueller, Ulrike Altenburger, Silke Mohl
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 29, 2006
NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implantsTilo Schönbrodt, Silke Mohl, Gerhard Winter, et al.
PDA Journal of Pharmaceutical Science and Technology|June 2, 2018
Evaluation of Container Closure System Integrity for Storage of Frozen Drug Products: Impact of Capping Force and TransportationAlejandra Nieto, Holger Roehl, Michael Adler, et al.
Pharmaceutical Research|March 24, 2007
New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implantsSandra Herrmann, Silke Mohl, Florence Siepmann, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 6, 2007
Mechanisms controlling protein release from lipidic implants: effects of PEG additionSandra Herrmann, Gerhard Winter, Silke Mohl, et al.
PDA Journal of Pharmaceutical Science and Technology|October 27, 2018
Residual Seal Force Testing: A Suitable Method for Seal Quality Determination of (High Potent) ParenteralsJakob W Buecheler, Joerg Luemkemann, Henning Gieseler, et al.
PDA Journal of Pharmaceutical Science and Technology|January 23, 2016
Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product ManufacturingRoman Mathaes, Hanns-Christian Mahler, Yves Roggo, et al.
PDA Journal of Pharmaceutical Science and Technology|February 19, 2016
Impact of Vial Capping on Residual Seal Force and Container Closure IntegrityRoman Mathaes, Hanns-Christian Mahler, Yves Roggo, et al.
Pageof 2